Regulation of chylomicron production in humans

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1821, Issue 5, 2012, Pages 736-746

  Xiao, Changting ^a   Lewis, Gary F ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Apolipoprotein B 48; Chylomicron; Human

Indexed keywords

ACYLTRANSFERASE INHIBITOR; APOLIPOPROTEIN B; APOLIPOPROTEIN B48; ATORVASTATIN; CHYLOMICRON; EZETIMIBE PLUS SIMVASTATIN; FATTY ACID; FENOFIBRATE; FRUCTOSE; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 2; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INCRETIN; INSULIN; LIPOPROTEIN LIPASE; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN INHIBITOR; PIOGLITAZONE; ROSIGLITAZONE; ROSUVASTATIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADIPOSE TISSUE; ATHEROGENESIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DYSLIPIDEMIA; FAT INTAKE; GENE MUTATION; GENETIC ASSOCIATION; HORMONAL REGULATION; HUMAN; HYDROLYSIS; HYPERLIPIDEMIA; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTESTINE CELL; LIFESTYLE MODIFICATION; LIPOGENESIS; LIPOLYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITIONAL PARAMETERS; OBESITY; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN METABOLISM; PROTEIN SYNTHESIS REGULATION; REVIEW; TRIACYLGLYCEROL BLOOD LEVEL;

APOLIPOPROTEIN B-48; CARDIOVASCULAR DISEASES; CHYLOMICRONS; DIABETES MELLITUS, TYPE 2; EATING; HUMANS; HYPERLIPIDEMIAS; INSULIN RESISTANCE; INTESTINES; LIPID METABOLISM; POSTPRANDIAL PERIOD;

EID: 84859158546     PISSN: 13881981     EISSN: 18792618     Source Type: Journal    
DOI: 10.1016/j.bbalip.2011.09.019     Document Type: Review

References (206)

1. K. Adeli, and G.F. Lewis Intestinal lipoprotein overproduction in insulin-resistant states Curr. Opin. Lipidol. 19 2008 221 228
2. M.K. Al, M.B. Cooper, B. Staels, G. Luc, M.R. Taskinen, and D.J. Betteridge The effect of sensitisation to insulin with pioglitazone on fasting and postprandial lipid metabolism, lipoprotein modification by lipases, and lipid transfer activities in type 2 diabetic patients Diabetologia 49 2006 527 537
3. S. Ali, and D.J. Drucker Benefits and limitations of reducing glucagon action for the treatment of type 2 diabetes Am. J. Physiol. Endocrinol. Metab. 296 2009 E415 E421
4. J.D. Bagdade, F.L. Dunn, R.H. Eckel, and M.C. Ritter Intraperitoneal insulin therapy corrects abnormalities in cholesteryl ester transfer and lipoprotein lipase activities in insulin-dependent diabetes mellitus Arterioscler. Thromb. 14 1994 1933 1939
5. L.L. Baggio, and D.J. Drucker Biology of incretins: GLP-1 and GIP Gastroenterology 132 2007 2131 2157
6. S. Bansal, J.E. Buring, N. Rifai, S. Mora, F.M. Sacks, and P.M. Ridker Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women JAMA 298 2007 309 316
7. P.A. Bateman, K.G. Jackson, V. Maitin, P. Yaqoob, and C.M. Williams Differences in cell morphology, lipid and apo B secretory capacity in caco-2 cells following long term treatment with saturated and monounsaturated fatty acids Biochim. Biophys. Acta 1771 2007 475 485
8. M.C. Batista, F.K. Welty, M.R. Diffenderfer, M.J. Sarnak, E.J. Schaefer, S. Lamon-Fava, B.F. Asztalos, G.G. Dolnikowski, M.E. Brousseau, and J.B. Marsh Apolipoprotein A-I, B-100, and B-48 metabolism in subjects with chronic kidney disease, obesity, and the metabolic syndrome Metabolism 53 2004 1255 1261
9. H.E. Bays, A.P. Tighe, R. Sadovsky, and M.H. Davidson Prescription omega-3 fatty acids and their lipid effects: physiologic mechanisms of action and clinical implications Expert Rev. Cardiovasc. Ther. 6 2008 391 409
10. A.M. Birch, L.K. Buckett, and A.V. Turnbull DGAT1 inhibitors as anti-obesity and anti-diabetic agents Curr. Opin. Drug Discov. Devel. 13 2010 489 496
11. P. Blackburn, B. Lamarche, C. Couillard, A. Pascot, N. Bergeron, D. Prud'homme, A. Tremblay, J. Bergeron, I. Lemieux, and J.P. Despres Postprandial hyperlipidemia: another correlate of the "hypertriglyceridemic waist" phenotype in men Atherosclerosis 171 2003 327 336
12. H.B. Brewer Jr., L.A. Zech, R.E. Gregg, D. Schwartz, and E.J. Schaefer NIH conference. Type III hyperlipoproteinemia: diagnosis, molecular defects, pathology, and treatment Ann. Intern. Med. 98 1983 623 640
13. J.D. Brunzell Familial lipoprotein lipase deficiency R.A. Pagon, T.D. Bird, C.R. Dolan, K. Stephens, Gene Reviews 1993 University of Washington Seattle
14. J.D. Brunzell, W.R. Hazzard, D. Porte Jr., and E.L. Bierman Evidence for a common, saturable, triglyceride removal mechanism for chylomicrons and very low density lipoproteins in man J. Clin. Invest. 52 1973 1578 1585
15. K.K. Buhman, S.J. Smith, S.J. Stone, J.J. Repa, J.S. Wong, F.F. Knapp Jr., B.J. Burri, R.L. Hamilton, N.A. Abumrad, and R.V. Farese Jr. DGAT1 is not essential for intestinal triacylglycerol absorption or chylomicron synthesis J. Biol. Chem. 277 2002 25474 25479
16. M.C. Bunck, A. Corner, B. Eliasson, R.J. Heine, R.M. Shaginian, Y. Wu, P. Yan, U. Smith, H. Yki-Jarvinen, M. Diamant, and M.R. Taskinen One-year treatment with exenatide vs. insulin glargine: effects on postprandial glycemia, lipid profiles, and oxidative stress Atherosclerosis 212 2010 223 229
17. M.C. Cabezas, T.W. de Bruin, H.E. Westerveld, E. Meijer, and D.W. Erkelens Delayed chylomicron remnant clearance in subjects with heterozygous familial hypercholesterolaemia J. Intern. Med. 244 1998 299 307
18. P.D. Cani, E. Joly, Y. Horsmans, and N.M. Delzenne Oligofructose promotes satiety in healthy human: a pilot study Eur. J. Clin. Nutr. 60 2006 567 572
19. J. Cao, E. Hawkins, J. Brozinick, X. Liu, H. Zhang, P. Burn, and Y. Shi A predominant role of acyl-CoA:monoacylglycerol acyltransferase-2 in dietary fat absorption implicated by tissue distribution, subcellular localization, and up-regulation by high fat diet J. Biol. Chem. 279 2004 18878 18886
20. A. Casaschi, G.K. Maiyoh, K. Adeli, and A.G. Theriault Increased diacylglycerol acyltransferase activity is associated with triglyceride accumulation in tissues of diet-induced insulin-resistant hyperlipidemic hamsters Metabolism 54 2005 403 409
21. A. Casaschi, Q. Wang, K. Dang, A. Richards, and A. Theriault Intestinal apolipoprotein B secretion is inhibited by the flavonoid quercetin: potential role of microsomal triglyceride transfer protein and diacylglycerol acyltransferase Lipids 37 2002 647 652
22. S. Cases, S.J. Smith, Y.W. Zheng, H.M. Myers, S.R. Lear, E. Sande, S. Novak, C. Collins, C.B. Welch, A.J. Lusis, S.K. Erickson, and R.V. Farese Jr. Identification of a gene encoding an acyl CoA:diacylglycerol acyltransferase, a key enzyme in triacylglycerol synthesis Proc. Natl. Acad. Sci. U. S. A. 95 1998 13018 13023
23. S. Cases, S.J. Stone, P. Zhou, E. Yen, B. Tow, K.D. Lardizabal, T. Voelker, and R.V. Farese Jr. Cloning of DGAT2, a second mammalian diacylglycerol acyltransferase, and related family members J. Biol. Chem. 276 2001 38870 38876
24. D.C. Chan, G.F. Watts, P.H. Barrett, J.C. Mamo, and T.G. Redgrave Markers of triglyceride-rich lipoprotein remnant metabolism in visceral obesity Clin. Chem. 48 2002 278 283
25. D.C. Chan, G.F. Watts, P.H. Barrett, I.J. Martins, A.P. James, J.C. Mamo, T.A. Mori, and T.G. Redgrave Effect of atorvastatin on chylomicron remnant metabolism in visceral obesity: a study employing a new stable isotope breath test J. Lipid Res. 43 2002 706 712
26. D.C. Chan, G.F. Watts, T.A. Mori, P.H. Barrett, T.G. Redgrave, and L.J. Beilin Randomized controlled trial of the effect of n-3 fatty acid supplementation on the metabolism of apolipoprotein B-100 and chylomicron remnants in men with visceral obesity Am. J. Clin. Nutr. 77 2003 300 307
27. D.C. Chan, G.F. Watts, T.W. Ng, S. Yamashita, and P.H. Barrett Effect of weight loss on markers of triglyceride-rich lipoprotein metabolism in the metabolic syndrome Eur. J. Clin. Invest. 38 2008 743 751
28. B. Chappuis, M. Braun, C. Stettler, S. Allemann, P. Diem, P.J. Lumb, A.S. Wierzbicki, R. James, and E.R. Christ Differential effect of pioglitazone (PGZ) and rosiglitazone (RGZ) on postprandial glucose and lipid metabolism in patients with type 2 diabetes mellitus: a prospective, randomized crossover study Diabetes Metab. Res. Rev. 23 2007 392 399
29. D. Cheng, T.C. Nelson, J. Chen, S.G. Walker, J. Wardwell-Swanson, R. Meegalla, R. Taub, J.T. Billheimer, M. Ramaker, and J.N. Feder Identification of acyl coenzyme A:monoacylglycerol acyltransferase 3, an intestinal specific enzyme implicated in dietary fat absorption J. Biol. Chem. 278 2003 13611 13614
30. J.S. Cohn Are we ready for a prospective study to investigate the role of chylomicrons in cardiovascular disease? Atheroscler. Suppl. 9 2008 15 18
31. J.S. Cohn, E.J. Johnson, J.S. Millar, S.D. Cohn, R.W. Milne, Y.L. Marcel, R.M. Russell, and E.J. Schaefer Contribution of apoB-48 and apoB-100 triglyceride-rich lipoproteins (TRL) to postprandial increases in the plasma concentration of TRL triglycerides and retinyl esters J. Lipid Res. 34 1993 2033 2040
32. J.S. Cohn, C. Marcoux, and J. Davignon Detection, quantification, and characterization of potentially atherogenic triglyceride-rich remnant lipoproteins Arterioscler. Thromb. Vasc. Biol. 19 1999 2474 2486
33. J.S. Cohn, J.R. McNamara, S.D. Krasinski, R.M. Russell, and E.J. Schaefer Role of triglyceride-rich lipoproteins from the liver and intestine in the etiology of postprandial peaks in plasma triglyceride concentration Metabolism 38 1989 484 490
34. A.D. Cooper Hepatic uptake of chylomicron remnants J. Lipid Res. 38 1997 2173 2192
35. M. Cuchel, L.T. Bloedon, P.O. Szapary, D.M. Kolansky, M.L. Wolfe, A. Sarkis, J.S. Millar, K. Ikewaki, E.S. Siegelman, R.E. Gregg, and D.J. Rader Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia N. Engl. J. Med. 356 2007 148 156
36. A. Curtin, P. Deegan, D. Owens, P. Collins, A. Johnson, and G.H. Tomkin Alterations in apolipoprotein B-48 in the postprandial state in NIDDM Diabetologia 37 1994 1259 1264
37. A. Curtin, P. Deegan, D. Owens, P. Collins, A. Johnson, and G.H. Tomkin Elevated triglyceride-rich lipoproteins in diabetes. A study of apolipoprotein B-48 Acta Diabetol. 33 1996 205 210
38. M. Dalgaard, C. Thomsen, B.M. Rasmussen, J.J. Holst, and K. Hermansen Ethanol with a mixed meal decreases the incretin levels early postprandially and increases postprandial lipemia in type 2 diabetic patients Metabolism 53 2004 77 83
39. C.A. Dane-Stewart, G.F. Watts, P.H. Barrett, B.G. Stuckey, J.C. Mamo, I.J. Martins, and T.G. Redgrave Chylomicron remnant metabolism studied with a new breath test in postmenopausal women with and without type 2 diabetes mellitus Clin. Endocrinol. (Oxf) 58 2003 415 420
40. C.A. Dane-Stewart, G.F. Watts, J.C. Mamo, P.H. Barrett, I.J. Martins, S.B. Dimmitt, and T.G. Redgrave Effect of Simvastatin on markers of triglyceride-rich lipoproteins in familial hypercholesterolaemia Eur. J. Clin. Invest. 32 2002 493 499
41. C.A. Dane-Stewart, G.F. Watts, J.C. Mamo, S.B. Dimmitt, P.H. Barrett, and T.G. Redgrave Elevated apolipoprotein B-48 and remnant-like particle-cholesterol in heterozygous familial hypercholesterolaemia Eur. J. Clin. Invest. 31 2001 113 117
42. C.A. Dane-Stewart, G.F. Watts, S. Pal, D. Chan, P. Thompson, J. Hung, and J.C. Mamo Effect of atorvastatin on apolipoprotein B48 metabolism and low-density lipoprotein receptor activity in normolipidemic patients with coronary artery disease Metabolism 52 2003 1279 1286
43. M.H. Davidson Mechanisms for the hypotriglyceridemic effect of marine omega-3 fatty acids Am. J. Cardiol. 98 2006 27i 33i
44. R.A. DeFronzo, T. Okerson, P. Viswanathan, X. Guan, J.H. Holcombe, and L. MacConell Effects of exenatide versus sitagliptin on postprandial glucose, insulin and glucagon secretion, gastric emptying, and caloric intake: a randomized, cross-over study Curr. Med. Res. Opin. 24 2008 2943 2952
45. M.J. Dekker, Q. Su, C. Baker, A.C. Rutledge, and K. Adeli Fructose: a highly lipogenic nutrient implicated in insulin resistance, hepatic steatosis, and the metabolic syndrome Am. J. Physiol. Endocrinol. Metab. 299 2010 E685 E694
46. C. Dubois, G. Beaumier, C. Juhel, M. Armand, H. Portugal, A.M. Pauli, P. Borel, C. Latge, and D. Lairon Effects of graded amounts (0-50 g) of dietary fat on postprandial lipemia and lipoproteins in normolipidemic adults Am. J. Clin. Nutr. 67 1998 31 38
47. H. Duez, B. Lamarche, K.D. Uffelman, R. Valero, J.S. Cohn, and G.F. Lewis Hyperinsulinemia is associated with increased production rate of intestinal apolipoprotein B-48-containing lipoproteins in humans Arterioscler. Thromb. Vasc. Biol. 26 2006 1357 1363
48. H. Duez, B. Lamarche, K.D. Uffelman, R. Valero, L. Szeto, S. Lemieux, J.S. Cohn, and G.F. Lewis Dissociation between the insulin-sensitizing effect of rosiglitazone and its effect on hepatic and intestinal lipoprotein production J. Clin. Endocrinol. Metab. 93 2008 1722 1729
49. H. Duez, B. Lamarche, R. Valero, M. Pavlic, S. Proctor, C. Xiao, L. Szeto, B.W. Patterson, and G.F. Lewis Both intestinal and hepatic lipoprotein production are stimulated by an acute elevation of plasma free fatty acids in humans Circulation 117 2008 2369 2376
50. H. Duez, M. Pavlic, and G.F. Lewis Mechanism of intestinal lipoprotein overproduction in insulin resistant humans Atheroscler. Suppl. 9 2008 33 38
51. P.D. Dworatzek, R.A. Hegele, and T.M. Wolever Postprandial lipemia in subjects with the threonine 54 variant of the fatty acid-binding protein 2 gene is dependent on the type of fat ingested Am. J. Clin. Nutr. 79 2004 1110 1117
52. D. Faeh, K. Minehira, J.M. Schwarz, R. Periasamy, S. Park, and L. Tappy Effect of fructose overfeeding and fish oil administration on hepatic de novo lipogenesis and insulin sensitivity in healthy men Diabetes 54 2005 1907 1913
53. L.M. Federico, M. Naples, D. Taylor, and K. Adeli Intestinal insulin resistance and aberrant production of apolipoprotein B48 lipoproteins in an animal model of insulin resistance and metabolic dyslipidemia: evidence for activation of protein tyrosine phosphatase-1B, extracellular signal-related kinase, and sterol regulatory element-binding protein-1c in the fructose-fed hamster intestine Diabetes 55 2006 1316 1326
54. B.A. Fielding, G. Reid, M. Grady, S.M. Humphreys, K. Evans, and K.N. Frayn Ethanol with a mixed meal increases postprandial triacylglycerol but decreases postprandial non-esterified fatty acid concentrations Br. J. Nutr. 83 2000 597 604
55. E.A. Fisher, and H.N. Ginsberg Complexity in the secretory pathway: the assembly and secretion of apolipoprotein B-containing lipoproteins J. Biol. Chem. 277 2002 17377 17380
56. H. Galbo, L. Tobin, and L.J. van Loon Responses to acute exercise in type 2 diabetes, with an emphasis on metabolism and interaction with oral hypoglycemic agents and food intake Appl. Physiol. Nutr. Metab. 32 2007 567 575
57. J.R. Galluzzi, L.A. Cupples, J.D. Otvos, P.W. Wilson, E.J. Schaefer, and J.M. Ordovas Association of the A/T54 polymorphism in the intestinal fatty acid binding protein with variations in plasma lipids in the Framingham Offspring Study Atherosclerosis 159 2001 417 424
58. R. Gambino, M. Cassader, G. Pagano, M. Durazzo, and G. Musso Polymorphism in microsomal triglyceride transfer protein: a link between liver disease and atherogenic postprandial lipid profile in NASH? Hepatology 45 2007 1097 1107
59. A. Gangl, and R.K. Ockner Intestinal metabolism of plasma free fatty acids. Intracellular compartmentation and mechanisms of control J. Clin. Invest. 55 1975 803 813
60. M. Gastaldi, S. Diziere, C. Defoort, H. Portugal, D. Lairon, M. Darmon, and R. Planells Sex-specific association of fatty acid binding protein 2 and microsomal triacylglycerol transfer protein variants with response to dietary lipid changes in the 3-mo Medi-RIVAGE primary intervention study Am. J. Clin. Nutr. 86 2007 1633 1641
61. A. Giacca, C. Xiao, A.I. Oprescu, A.C. Carpentier, and G.F. Lewis Lipid-induced pancreatic beta-cell dysfunction: focus on in vivo studies Am. J. Physiol. Endocrinol. Metab. 300 2011 E255 E262
62. R.B. Goldberg, D.M. Kendall, M.A. Deeg, J.B. Buse, A.J. Zagar, J.A. Pinaire, M.H. Tan, M.A. Khan, A.T. Perez, and S.J. Jacober A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia Diabetes Care 28 2005 1547 1554
63. M. Gomaraschi, W.E. Putt, S. Pozzi, S. Iametti, A. Barbiroli, F. Bonomi, E. Favari, F. Bernini, G. Franceschini, P.J. Talmud, and L. Calabresi Structure and function of the apoA-IV T347S and Q360H common variants Biochem. Biophys. Res. Commun. 393 2010 126 130
64. Q. Guo, R.K. Avramoglu, and K. Adeli Intestinal assembly and secretion of highly dense/lipid-poor apolipoprotein B48-containing lipoprotein particles in the fasting state: evidence for induction by insulin resistance and exogenous fatty acids Metabolism 54 2005 689 697
65. M. Haidari, N. Leung, F. Mahbub, K.D. Uffelman, R. Kohen-Avramoglu, G.F. Lewis, and K. Adeli Fasting and postprandial overproduction of intestinally derived lipoproteins in an animal model of insulin resistance. Evidence that chronic fructose feeding in the hamster is accompanied by enhanced intestinal de novo lipogenesis and ApoB48-containing lipoprotein overproduction J. Biol. Chem. 277 2002 31646 31655
66. A. Hammoud, M. Gastaldi, M. Maillot, C.S. Mercier, C. Defoort, D. Lairon, and R. Planells APOB-516 T allele homozygous subjects are unresponsive to dietary changes in a three-month primary intervention study targeted to reduce fat intake Genes Nutr. 5 2010 29 37
67. L.H. Hansen, N. Abrahamsen, and E. Nishimura Glucagon receptor mRNA distribution in rat tissues Peptides 16 1995 1163 1166
68. A. Harbis, C. Defoort, H. Narbonne, C. Juhel, M. Senft, C. Latge, B. Delenne, H. Portugal, C. Atlan-Gepner, B. Vialettes, and D. Lairon Acute hyperinsulinism modulates plasma apolipoprotein B-48 triglyceride-rich lipoproteins in healthy subjects during the postprandial period Diabetes 50 2001 462 469
69. W.S. Harris, W.E. Connor, N. Alam, and D.R. Illingworth Reduction of postprandial triglyceridemia in humans by dietary n-3 fatty acids J. Lipid Res. 29 1988 1451 1460
70. W.S. Harris, and F. Muzio Fish oil reduces postprandial triglyceride concentrations without accelerating lipid-emulsion removal rates Am. J. Clin. Nutr. 58 1993 68 74
71. T. Hata, Y. Mera, Y. Ishii, H. Tadaki, D. Tomimoto, Y. Kuroki, T. Ota, T. Kawai, and M. Kakutani JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, suppresses food intake and gastric emptying with the elevation of plasma peptide YY and glucagon-like peptide-1 in a dietary fat-dependent manner J. Pharmacol. Exp. Ther. 336 2011 850 856
72. J.C. Hogue, B. Lamarche, Y. Deshaies, A.J. Tremblay, J. Bergeron, C. Gagne, and P. Couture Differential effect of fenofibrate and atorvastatin on in vivo kinetics of apolipoproteins B-100 and B-48 in subjects with type 2 diabetes mellitus with marked hypertriglyceridemia Metabolism 57 2008 246 254
73. J.C. Hogue, B. Lamarche, A.J. Tremblay, J. Bergeron, C. Gagne, and P. Couture Evidence of increased secretion of apolipoprotein B-48-containing lipoproteins in subjects with type 2 diabetes J. Lipid Res. 48 2007 1336 1342
74. C.B. Hollenbeck, A.M. Coulston, and G.M. Reaven Effects of sucrose on carbohydrate and lipid metabolism in NIDDM patients Diabetes Care 12 1989 62 66
75. A.J. Hooper, K. Robertson, P.H. Barrett, K.G. Parhofer, F.M. van Bockxmeer, and J.R. Burnett Postprandial lipoprotein metabolism in familial hypobetalipoproteinemia J. Clin. Endocrinol. Metab. 92 2007 1474 1478
76. J. Hsieh, C. Longuet, C.L. Baker, B. Qin, L.M. Federico, D.J. Drucker, and K. Adeli The glucagon-like peptide 1 receptor is essential for postprandial lipoprotein synthesis and secretion in hamsters and mice Diabetologia 53 2010 552 561
77. J. Hsieh, C. Longuet, A. Maida, J. Bahrami, E. Xu, C.L. Baker, P.L. Brubaker, D.J. Drucker, and K. Adeli Glucagon-like peptide-2 increases intestinal lipid absorption and chylomicron production via CD36 Gastroenterology 137 2009 997 1005 1005.
78. M.W. Huff Dietary cholesterol, cholesterol absorption, postprandial lipemia and atherosclerosis Can. J. Clin. Pharmacol. 10 Suppl. A 2003 26A 32A
79. M.M. Hussain A proposed model for the assembly of chylomicrons Atherosclerosis 148 2000 1 15
80. M.M. Hussain, S. Fatma, X. Pan, and J. Iqbal Intestinal lipoprotein assembly Curr. Opin. Lipidol. 16 2005 281 285
81. M.M. Hussain, P. Rava, X. Pan, K. Dai, S.K. Dougan, J. Iqbal, F. Lazare, and I. Khatun Microsomal triglyceride transfer protein in plasma and cellular lipid metabolism Curr. Opin. Lipidol. 19 2008 277 284
82. M.M. Hussain, J. Shi, and P. Dreizen Microsomal triglyceride transfer protein and its role in apoB-lipoprotein assembly J. Lipid Res. 44 2003 22 32
83. K. Ikewaki, W. Cain, F. Thomas, R. Shamburek, L.A. Zech, D. Usher, H.B. Brewer Jr., and D.J. Rader Abnormal in vivo metabolism of apoB-containing lipoproteins in human apoE deficiency J. Lipid Res. 45 2004 1302 1311
84. K. Ikewaki, D.J. Rader, J.R. Schaefer, T. Fairwell, L.A. Zech, and H.B. Brewer Jr. Evaluation of apoA-I kinetics in humans using simultaneous endogenous stable isotope and exogenous radiotracer methods J. Lipid Res. 34 1993 2207 2215
85. J. Iqbal, K. Dai, T. Seimon, R. Jungreis, M. Oyadomari, G. Kuriakose, D. Ron, I. Tabas, and M.M. Hussain IRE1beta inhibits chylomicron production by selectively degrading MTP mRNA Cell Metab. 7 2008 445 455
86. J. Iqbal, and M.M. Hussain Intestinal lipid absorption Am. J. Physiol. Endocrinol. Metab. 296 2009 E1183 E1194
87. K.G. Jackson, E.J. Wolstencroft, P.A. Bateman, P. Yaqoob, and C.M. Williams Greater enrichment of triacylglycerol-rich lipoproteins with apolipoproteins E and C-III after meals rich in saturated fatty acids than after meals rich in unsaturated fatty acids Am. J. Clin. Nutr. 81 2005 25 34
88. K.G. Jackson, A. Zampelas, J.M. Knapper, H.M. Roche, M.J. Gibney, A. Kafatos, B.J. Gould, J.W. Wright, and C.M. Williams Differences in glucose-dependent insulinotrophic polypeptide hormone and hepatic lipase in subjects of southern and northern Europe: implications for postprandial lipemia Am. J. Clin. Nutr. 71 2000 13 20
89. A.P. James, K. Slivkoff-Clark, and J.C. Mamo Prior exercise does not affect chylomicron particle number following a mixed meal of moderate fat content Lipids Health Dis. 6 2007 8
90. A.P. James, G.F. Watts, P.H. Barrett, D. Smith, S. Pal, D.C. Chan, and J.C. Mamo Effect of weight loss on postprandial lipemia and low-density lipoprotein receptor binding in overweight men Metabolism 52 2003 136 141
91. A.P. James, G.F. Watts, and J.C. Mamo The effect of metformin and rosiglitazone on postprandial lipid metabolism in obese insulin-resistant subjects Diabetes Obes. Metab. 7 2005 381 389
92. F. Karpe, G. Steiner, K. Uffelman, T. Olivecrona, and A. Hamsten Postprandial lipoproteins and progression of coronary atherosclerosis Atherosclerosis 106 1994 83 97
93. E. Kim, S. Campbell, O. Schueller, E. Wong, B. Cole, J. Kuo, J. Ferkany, J. Ellis, and P. Sweetnam A small molecule inhibitor of enterocytic microsomal triglyceride transfer protein; SLx-4090, biochemical, pharmacodynamic, pharmacokinetic and safety profile J. Pharmacol. Exp. Ther. 337 2011 775 785
94. D.C. Klonoff, J.B. Buse, L.L. Nielsen, X. Guan, C.L. Bowlus, J.H. Holcombe, M.E. Wintle, and D.G. Maggs Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years Curr. Med. Res. Opin. 24 2008 275 286
95. J. Kobayashi, K. Nakajima, A. Nohara, M. Kawashiri, K. Yagi, A. Inazu, J. Koizumi, M. Yamagishi, and H. Mabuchi The relationship of serum lipoprotein lipase mass with fasting serum apolipoprotein B-48 and remnant-like particle triglycerides in type 2 diabetic patients Horm. Metab. Res. 39 2007 612 616
96. T. Kuwasako, K. Hirano, N. Sakai, M. Ishigami, H. Hiraoka, M.J. Yakub, K. Yamauchi-Takihara, S. Yamashita, and Y. Matsuzawa Lipoprotein abnormalities in human genetic CD36 deficiency associated with insulin resistance and abnormal fatty acid metabolism Diabetes Care 26 2003 1647 1648
97. D. Lairon Macronutrient intake and modulation on chylomicron production and clearance Atheroscler. Suppl. 9 2008 45 48
98. S. Lally, C.Y. Tan, D. Owens, and G.H. Tomkin Messenger RNA levels of genes involved in dysregulation of postprandial lipoproteins in type 2 diabetes: the role of Niemann-Pick C1-like 1, ATP-binding cassette, transporters G5 and G8, and of microsomal triglyceride transfer protein Diabetologia 49 2006 1008 1016
99. S. Lamon-Fava, M.R. Diffenderfer, P.H. Barrett, A. Buchsbaum, M. Nyaku, K.V. Horvath, B.F. Asztalos, S. Otokozawa, M. Ai, N.R. Matthan, A.H. Lichtenstein, G.G. Dolnikowski, and E.J. Schaefer Extended-release niacin alters the metabolism of plasma apolipoprotein (Apo) A-I and ApoB-containing lipoproteins Arterioscler. Thromb. Vasc. Biol. 28 2008 1672 1678
100. B. Lee, A.M. Fast, J. Zhu, J.X. Cheng, and K.K. Buhman Intestine-specific expression of acyl CoA:diacylglycerol acyltransferase 1 reverses resistance to diet-induced hepatic steatosis and obesity in Dgat1-/- mice J. Lipid Res. 51 2010 1770 1780
101. Y. Lee, M.Y. Wang, X.Q. Du, M.J. Charron, and R.H. Unger Glucagon receptor knockout prevents insulin-deficient type 1 diabetes in mice Diabetes 60 2011 391 397
102. N. Leung, M. Naples, K. Uffelman, L. Szeto, K. Adeli, and G.F. Lewis Rosiglitazone improves intestinal lipoprotein overproduction in the fat-fed Syrian Golden hamster, an animal model of nutritionally-induced insulin resistance Atherosclerosis 174 2004 235 241
103. E. Levy, D. Sinnett, L. Thibault, T.D. Nguyen, E. Delvin, and D. Menard Insulin modulation of newly synthesized apolipoproteins B-100 and B-48 in human fetal intestine: gene expression and mRNA editing are not involved FEBS Lett. 393 1996 253 258
104. G.F. Lewis Postprandial lipoprotein metabolism in diabetes mellitus and obesity J. Atheroscler. Thromb. 2 Suppl. 1 1995 S34 S35
105. G.F. Lewis Fatty acid regulation of very low density lipoprotein production Curr. Opin. Lipidol. 8 1997 146 153
106. G.F. Lewis, A. Carpentier, K. Adeli, and A. Giacca Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes Endocr. Rev. 23 2002 201 229
107. G.F. Lewis, M. Naples, K. Uffelman, N. Leung, L. Szeto, and K. Adeli Intestinal lipoprotein production is stimulated by an acute elevation of plasma free fatty acids in the fasting state: studies in insulin-resistant and insulin-sensitized Syrian golden hamsters Endocrinology 145 2004 5006 5012
108. G.F. Lewis, N.M. O'Meara, P.A. Soltys, J.D. Blackman, P.H. Iverius, W.L. Pugh, G.S. Getz, and K.S. Polonsky Fasting hypertriglyceridemia in noninsulin-dependent diabetes mellitus is an important predictor of postprandial lipid and lipoprotein abnormalities J. Clin. Endocrinol. Metab. 72 1991 934 944
109. G.F. Lewis, K. Uffelman, M. Naples, L. Szeto, M. Haidari, and K. Adeli Intestinal lipoprotein overproduction, a newly recognized component of insulin resistance, is ameliorated by the insulin sensitizer rosiglitazone: studies in the fructose-fed Syrian golden hamster Endocrinology 146 2005 247 255
110. A.H. Lichtenstein, D.L. Hachey, J.S. Millar, J.L. Jenner, L. Booth, J. Ordovas, and E.J. Schaefer Measurement of human apolipoprotein B-48 and B-100 kinetics in triglyceride-rich lipoproteins using [5,5,5-2H3]leucine J. Lipid Res. 33 1992 907 914
111. J. Lopez-Miranda, J.M. Ordovas, M.A. Ostos, C. Marin, S. Jansen, J. Salas, A. Blanco-Molina, J.A. Jimenez-Pereperez, F. Lopez-Segura, and F. Perez-Jimenez Dietary fat clearance in normal subjects is modulated by genetic variation at the apolipoprotein B gene locus Arterioscler. Thromb. Vasc. Biol. 17 1997 1765 1773
112. J.A. Lovshin, and D.J. Drucker Incretin-based therapies for type 2 diabetes mellitus Nat. Rev. Endocrinol. 5 2009 262 269
113. S. Lu, Y. Yao, X. Cheng, S. Mitchell, S. Leng, S. Meng, J.W. Gallagher, G.S. Shelness, G.S. Morris, J. Mahan, S. Frase, C.M. Mansbach, R.B. Weinberg, and D.D. Black Overexpression of apolipoprotein A-IV enhances lipid secretion in IPEC-1 cells by increasing chylomicron size J. Biol. Chem. 281 2006 3473 3483
114. B. Lundahl, A. Hamsten, and F. Karpe Postprandial plasma ApoB-48 levels are influenced by a polymorphism in the promoter of the microsomal triglyceride transfer protein gene Arterioscler. Thromb. Vasc. Biol. 22 2002 289 293
115. Y. Luo, L. Shelly, T. Sand, G. Chang, and X.C. Jiang Identification and characterization of dual inhibitors for phospholipid transfer protein and microsomal triglyceride transfer protein J. Pharmacol. Exp. Ther. 335 2010 653 658
116. X. Ma, S. Bacci, W. Mlynarski, L. Gottardo, T. Soccio, C. Menzaghi, E. Iori, R.A. Lager, A.R. Shroff, E.V. Gervino, R.W. Nesto, M.T. Johnstone, N.A. Abumrad, A. Avogaro, V. Trischitta, and A. Doria A common haplotype at the CD36 locus is associated with high free fatty acid levels and increased cardiovascular risk in Caucasians Hum. Mol. Genet. 13 2004 2197 2205
117. J.C. Mamo, A.P. James, M.J. Soares, D.G. Griffiths, K. Purcell, and J.L. Schwenke A low-protein diet exacerbates postprandial chylomicron concentration in moderately dyslipidaemic subjects in comparison to a lean red meat protein-enriched diet Eur. J. Clin. Nutr. 59 2005 1142 1148
118. J.C. Mamo, G.F. Watts, P.H. Barrett, D. Smith, A.P. James, and S. Pal Postprandial dyslipidemia in men with visceral obesity: an effect of reduced LDL receptor expression? Am. J. Physiol. Endocrinol. Metab. 281 2001 E626 E632
119. R. Mangat, J.W. Su, J.E. Lambert, M.T. Clandinin, Y. Wang, R.R. Uwiera, J.M. Forbes, D.F. Vine, M.E. Cooper, J.C. Mamo, and S.D. Proctor Increased risk of cardiovascular disease in Type 1 diabetes: arterial exposure to remnant lipoproteins leads to enhanced deposition of cholesterol and binding to glycated extracellular matrix proteoglycans Diabet. Med. 28 2011 61 72
120. N. Matikainen, S. Manttari, A. Schweizer, A. Ulvestad, D. Mills, B.E. Dunning, J.E. Foley, and M.R. Taskinen Vildagliptin therapy reduces postprandial intestinal triglyceride-rich lipoprotein particles in patients with type 2 diabetes Diabetologia 49 2006 2049 2057
121. J.J. Meier, A. Gethmann, O. Gotze, B. Gallwitz, J.J. Holst, W.E. Schmidt, and M.A. Nauck Glucagon-like peptide 1 abolishes the postprandial rise in triglyceride concentrations and lowers levels of non-esterified fatty acids in humans Diabetologia 49 2006 452 458
122. J.J. Meier, and M.A. Nauck Incretins and the development of type 2 diabetes Curr. Diab. Rep. 6 2006 194 201
123. J.J. Meier, M.A. Nauck, A. Pott, K. Heinze, O. Goetze, K. Bulut, W.E. Schmidt, B. Gallwitz, and J.J. Holst Glucagon-like peptide 2 stimulates glucagon secretion, enhances lipid absorption, and inhibits gastric acid secretion in humans Gastroenterology 130 2006 44 54
124. M.S. Meng, R.E. Gregg, E.J. Schaefer, J.M. Hoeg, and H.B. Brewer Jr. Presence of two forms of apolipoprotein B in patients with dyslipoproteinemia J. Lipid Res. 24 1983 803 809
125. Y. Mera, N. Odani, T. Kawai, T. Hata, M. Suzuki, A. Hagiwara, T. Katsushima, and M. Kakutani Pharmacological characterization of diethyl-2-({3-dimethylcarbamoyl-4-[(4'-trifluoromethylbiphenyl-2-carbonyl) amino]phenyl}acetyloxymethyl)-2-phenylmalonate (JTT-130), an intestine-specific inhibitor of microsomal triglyceride transfer protein J. Pharmacol. Exp. Ther. 336 2011 321 327
126. N. Mero, L. Suurinkeroinen, M. Syvanne, P. Knudsen, H. Yki-Jarvinen, and M.R. Taskinen Delayed clearance of postprandial large TG-rich particles in normolipidemic carriers of LPL Asn291Ser gene variant J. Lipid Res. 40 1999 1663 1670
127. N. Mero, M. Syvanne, and M.R. Taskinen Postprandial lipid metabolism in diabetes Atherosclerosis 141 Suppl. 1 1998 S53 S55
128. J.A. Moreno, J. Lopez-Miranda, C. Marin, P. Gomez, P. Perez-Martinez, F. Fuentes, R.A. Fernandez de la Puebla, J.A. Paniagua, J.M. Ordovas, and F. Perez-Jimenez The influence of the apolipoprotein E gene promoter (- 219G/ T) polymorphism on postprandial lipoprotein metabolism in young normolipemic males J. Lipid Res. 44 2003 2059 2064
129. R. Moreno-Luna, F. Perez-Jimenez, C. Marin, P. Perez-Martinez, P. Gomez, Y. Jimenez-Gomez, J. Delgado-Lista, J.A. Moreno, T. Tanaka, J.M. Ordovas, and J. Lopez-Miranda Two independent apolipoprotein A5 haplotypes modulate postprandial lipoprotein metabolism in a healthy Caucasian population J. Clin. Endocrinol. Metab. 92 2007 2280 2285
130. M.C. Murphy, S.G. Isherwood, S. Sethi, B.J. Gould, J.W. Wright, J.A. Knapper, and C.M. Williams Postprandial lipid and hormone responses to meals of varying fat contents: modulatory role of lipoprotein lipase? Eur. J. Clin. Nutr. 49 1995 578 588
131. G. Musso, R. Gambino, G. Pacini, M.F. De, and M. Cassader Prolonged saturated fat-induced, glucose-dependent insulinotropic polypeptide elevation is associated with adipokine imbalance and liver injury in nonalcoholic steatohepatitis: dysregulated enteroadipocyte axis as a novel feature of fatty liver Am. J. Clin. Nutr. 89 2009 558 567
132. K. Nagashima, C. Lopez, D. Donovan, C. Ngai, N. Fontanez, A. Bensadoun, J. Fruchart-Najib, S. Holleran, J.S. Cohn, R. Ramakrishnan, and H.N. Ginsberg Effects of the PPARgamma agonist pioglitazone on lipoprotein metabolism in patients with type 2 diabetes mellitus J. Clin. Invest. 115 2005 1323 1332
133. M.C. Nierman, J. Rip, J.A. Kuivenhoven, N. Sakai, J.J. Kastelein, M.G. de Sain-van der Velden, E.S. Stroes, and B.H. Prinsen Enhanced apoB48 metabolism in lipoprotein lipase X447 homozygotes Atherosclerosis 194 2007 446 451
134. J.P. Nogueir, M. Maraninchi, S. Béliard, N. Padilla, L. Duvillard, J. Mancini, A. Nicolay, C. Xiao, B. Vialettes, G.F. Lewis, R. Valero, Absence of acute inhibitory effect of insulin on chylomicron production in type 2 diabetes, Arterioscler. Thromb. Vasc. Biol. (in revision).
135. B.G. Nordestgaard, M. Benn, P. Schnohr, and A. Tybjaerg-Hansen Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women JAMA 298 2007 299 308
136. G. Olivecrona, E. Ehrenborg, H. Semb, E. Makoveichuk, A. Lindberg, M.R. Hayden, P. Gin, B.S. Davies, M.M. Weinstein, L.G. Fong, A.P. Beigneux, S.G. Young, T. Olivecrona, and O. Hernell Mutation of conserved cysteines in the Ly6 domain of GPIHBP1 in familial chylomicronemia J. Lipid Res. 51 2010 1535 1545
137. S. Otokozawa, M. Ai, M.R. Diffenderfer, B.F. Asztalos, A. Tanaka, S. Lamon-Fava, and E.J. Schaefer Fasting and postprandial apolipoprotein B-48 levels in healthy, obese, and hyperlipidemic subjects Metabolism 58 2009 1536 1542
138. S. Otokozawa, M. Ai, H.T. Van, B.F. Asztalos, A. Tanaka, E.A. Stein, P.H. Jones, and E.J. Schaefer Effects of intensive atorvastatin and rosuvastatin treatment on apolipoprotein B-48 and remnant lipoprotein cholesterol levels Atherosclerosis 205 2009 197 201
139. S. Pal, S.S. Ho, and R. Takechi Red wine polyphenolics suppress the secretion of ApoB48 from human intestinal CaCo-2 cells J. Agric. Food Chem. 53 2005 2767 2772
140. M. Pan, A.I. Cederbaum, Y.L. Zhang, H.N. Ginsberg, K.J. Williams, and E.A. Fisher Lipid peroxidation and oxidant stress regulate hepatic apolipoprotein B degradation and VLDL production J. Clin. Invest. 113 2004 1277 1287
141. Y. Park, and W.S. Harris Omega-3 fatty acid supplementation accelerates chylomicron triglyceride clearance J. Lipid Res. 44 2003 455 463
142. E.J. Parks Effect of dietary carbohydrate on triglyceride metabolism in humans J. Nutr. 131 2001 2772S 2774S
143. E.J. Parks, and M.K. Hellerstein Carbohydrate-induced hypertriacylglycerolemia: historical perspective and review of biological mechanisms Am. J. Clin. Nutr. 71 2000 412 433
144. J. Patsch Influence of lipolysis on chylomicron clearance and HDL cholesterol levels Eur. Heart J. 19 Suppl. H 1998 H2 H6
145. M. Pavlic, C. Xiao, L. Szeto, B.W. Patterson, and G.F. Lewis Insulin acutely inhibits intestinal lipoprotein secretion in humans in part by suppressing plasma free fatty acids Diabetes 59 2010 580 587
146. R.E. Peacock, F. Karpe, P.J. Talmud, A. Hamsten, and S.E. Humphries Common variation in the gene for apolipoprotein B modulates postprandial lipoprotein metabolism: a hypothesis generating study Atherosclerosis 116 1995 135 145
147. N. Peretti, C.C. Roy, E. Drouin, E. Seidman, P. Brochu, G. Casimir, and E. Levy Abnormal intracellular lipid processing contributes to fat malabsorption in cystic fibrosis patients Am. J. Physiol. Gastrointest. Liver Physiol. 290 2006 G609 G615
148. N. Peretti, C.C. Roy, A. Sassolas, C. Deslandres, E. Drouin, A. Rasquin, E. Seidman, P. Brochu, M.C. Vohl, S. Labarge, R. Bouvier, M.E. Samson-Bouma, M. Charcosset, A. Lachaux, and E. Levy Chylomicron retention disease: a long term study of two cohorts Mol. Genet. Metab. 97 2009 136 142
149. P. Perez-Martinez, F. Perez-Jimenez, J.M. Ordovas, J.A. Moreno, C. Marin, R. Moreno, Y. Jimenez-Gomez, J.A. Paniagua, and J. Lopez-Miranda Postprandial lipemia is modified by the presence of the APOB-516C/T polymorphism in a healthy Caucasian population Lipids 42 2007 143 150
150. C. Phillips, A. Bennett, K. Anderton, D. Owens, P. Collins, D. White, and G.H. Tomkin Intestinal rather than hepatic microsomal triglyceride transfer protein as a cause of postprandial dyslipidemia in diabetes Metabolism 51 2002 847 852
151. C. Phillips, K. Mullan, D. Owens, and G.H. Tomkin Microsomal triglyceride transfer protein polymorphisms and lipoprotein levels in type 2 diabetes QJM 97 2004 211 218
152. C. Phillips, G. Murugasu, D. Owens, P. Collins, A. Johnson, and G.H. Tomkin Improved metabolic control reduces the number of postprandial apolipoprotein B-48-containing particles in type 2 diabetes Atherosclerosis 148 2000 283 291
153. M.L. Phillips, C. Pullinger, I. Kroes, J. Kroes, D.A. Hardman, G. Chen, L.K. Curtiss, M.M. Gutierrez, J.P. Kane, and V.N. Schumaker A single copy of apolipoprotein B-48 is present on the human chylomicron remnant J. Lipid Res. 38 1997 1170 1177
154. T. Piche, S.B. des Varannes, S. Sacher-Huvelin, J.J. Holst, J.C. Cuber, and J.P. Galmiche Colonic fermentation influences lower esophageal sphincter function in gastroesophageal reflux disease Gastroenterology 124 2003 894 902
155. D.A. Popper, Y.F. Shiau, and M. Reed Role of small intestine in pathogenesis of hyperlipidemia in diabetic rats Am. J. Physiol. 249 1985 G161 G167
156. L.M. Powell, S.C. Wallis, R.J. Pease, Y.H. Edwards, T.J. Knott, and J. Scott A novel form of tissue-specific RNA processing produces apolipoprotein-B48 in intestine Cell 50 1987 831 840
157. S.D. Proctor, and J.C. Mamo Retention of fluorescent-labelled chylomicron remnants within the intima of the arterial wall-evidence that plaque cholesterol may be derived from post-prandial lipoproteins Eur. J. Clin. Invest. 28 1998 497 503
158. S.D. Proctor, and J.C. Mamo Intimal retention of cholesterol derived from apolipoprotein B100- and apolipoprotein B48-containing lipoproteins in carotid arteries of Watanabe heritable hyperlipidemic rabbits Arterioscler. Thromb. Vasc. Biol. 23 2003 1595 1600
159. S.D. Proctor, D.F. Vine, and J.C. Mamo Arterial permeability and efflux of apolipoprotein B-containing lipoproteins assessed by in situ perfusion and three-dimensional quantitative confocal microscopy Arterioscler. Thromb. Vasc. Biol. 24 2004 2162 2167
160. B. Qin, W. Qiu, R.K. Avramoglu, and K. Adeli Tumor necrosis factor-alpha induces intestinal insulin resistance and stimulates the overproduction of intestinal apolipoprotein B48-containing lipoproteins Diabetes 56 2007 450 461
161. X. Qin, H. Shen, M. Liu, Q. Yang, S. Zheng, M. Sabo, D.A. D'Alessio, and P. Tso GLP-1 reduces intestinal lymph flow, triglyceride absorption, and apolipoprotein production in rats Am. J. Physiol. Gastrointest. Liver Physiol. 288 2005 G943 G949
162. M. Raabe, M.M. Veniant, M.A. Sullivan, C.H. Zlot, J. Bjorkegren, L.B. Nielsen, J.S. Wong, R.L. Hamilton, and S.G. Young Analysis of the role of microsomal triglyceride transfer protein in the liver of tissue-specific knockout mice J. Clin. Invest. 103 1999 1287 1298
163. D.J. Rader, and H.B. Brewer Jr. Abetalipoproteinemia. New insights into lipoprotein assembly and vitamin E metabolism from a rare genetic disease JAMA 270 1993 865 869
164. G.M. Reaven Do high carbohydrate diets prevent the development or attenuate the manifestations (or both) of syndrome X? A viewpoint strongly against Curr. Opin. Lipidol. 8 1997 23 27
165. M.D. Robertson, M. Parkes, B.F. Warren, D.J. Ferguson, K.G. Jackson, D.P. Jewell, and K.N. Frayn Mobilisation of enterocyte fat stores by oral glucose in humans Gut 52 2003 834 839
166. D.C. Rubinsztein, J.C. Cohen, G.M. Berger, D.R. van der Westhuyzen, G.A. Coetzee, and W. Gevers Chylomicron remnant clearance from the plasma is normal in familial hypercholesterolemic homozygotes with defined receptor defects J. Clin. Invest. 86 1990 1306 1312
167. F.F. Samaha, J. McKenney, L.T. Bloedon, W.J. Sasiela, and D.J. Rader Inhibition of microsomal triglyceride transfer protein alone or with ezetimibe in patients with moderate hypercholesterolemia Nat. Clin. Pract. Cardiovasc. Med. 5 2008 497 505
168. E.J. Schaefer, J.R. McNamara, P.K. Shah, K. Nakajima, L.A. Cupples, J.M. Ordovas, and P.W. Wilson Elevated remnant-like particle cholesterol and triglyceride levels in diabetic men and women in the Framingham Offspring Study Diabetes Care 25 2002 989 994
169. E.A. Schwartz, J. Koska, M.P. Mullin, I. Syoufi, D.C. Schwenke, and P.D. Reaven Exenatide suppresses postprandial elevations in lipids and lipoproteins in individuals with impaired glucose tolerance and recent onset type 2 diabetes mellitus Atherosclerosis 212 2010 217 222
170. S.L. Schwartz, R.E. Ratner, D.D. Kim, Y. Qu, L.L. Fechner, S.M. Lenox, and J.H. Holcombe Effect of exenatide on 24-hour blood glucose profile compared with placebo in patients with type 2 diabetes: a randomized, double-blind, two-arm, parallel-group, placebo-controlled, 2-week study Clin. Ther. 30 2008 858 867
171. A. Shah, D.J. Rader, and J.S. Millar The effect of PPAR-alpha agonism on apolipoprotein metabolism in humans Atherosclerosis 210 2010 35 40
172. Y. Shi, and D. Cheng Beyond triglyceride synthesis: the dynamic functional roles of MGAT and DGAT enzymes in energy metabolism Am. J. Physiol. Endocrinol. Metab. 297 2009 E10 E18
173. S.J. Smith, S. Cases, D.R. Jensen, H.C. Chen, E. Sande, B. Tow, D.A. Sanan, J. Raber, R.H. Eckel, and R.V. Farese Jr. Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking Dgat Nat. Genet. 25 2000 87 90
174. K.L. Stanhope, J.M. Schwarz, N.L. Keim, S.C. Griffen, A.A. Bremer, J.L. Graham, B. Hatcher, C.L. Cox, A. Dyachenko, W. Zhang, J.P. McGahan, A. Seibert, R.M. Krauss, S. Chiu, E.J. Schaefer, M. Ai, S. Otokozawa, K. Nakajima, T. Nakano, C. Beysen, M.K. Hellerstein, L. Berglund, and P.J. Havel Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans J. Clin. Invest. 119 2009 1322 1334
175. J.W. Su, J.E. Lambert, M.T. Clandinin, and S.D. Proctor Impaired postprandial metabolism of apolipoprotein B48-containing remnant particles in normolipidemic subjects with brittle type 1 diabetes Diabetes Care 32 2009 e21
176. J.W. Su, M.M. Nzekwu, M.C. Cabezas, T. Redgrave, and S.D. Proctor Methods to assess impaired post-prandial metabolism and the impact for early detection of cardiovascular disease risk Eur. J. Clin. Invest. 39 2009 741 754
177. J.W. Su, M.M. Ugo Nzekwu, G.D. Ball, M.M. Jetha, and S.D. Proctor Postprandial lipemia as an early predictor of cardiovascular complications in childhood obesity J. Clin. Lipidol. 3 2009 78 84
178. G.D. Tan, B.A. Fielding, J.M. Currie, S.M. Humphreys, M. Desage, K.N. Frayn, M. Laville, H. Vidal, and F. Karpe The effects of rosiglitazone on fatty acid and triglyceride metabolism in type 2 diabetes Diabetologia 48 2005 83 95
179. S. Tanaka, Y. Tanabe, H. Tamura, S. Ishii, Y. Shuto, J. Kamegai, H. Sugihara, M. Kobayashi, I. Wakabayashi, T. Murano, K. Shirai, and S. Oikawa Chylomicronemia caused by lipoprotein lipase gene mutation related to a hyper-response of insulin secretion to glucose Intern. Med. 41 2002 300 303
180. A. Taniguchi, M. Fukushima, M. Sakai, K. Miwa, T. Makita, I. Nagata, S. Nagasaka, K. Doi, T. Okumura, A. Fukuda, H. Kishimoto, T. Fukuda, S. Nakaishi, K. Tokuyama, and Y. Nakai Remnant-like particle cholesterol, triglycerides, and insulin resistance in nonobese Japanese type 2 diabetic patients Diabetes Care 23 2000 1766 1769
181. L.W. Tobin, B. Kiens, and H. Galbo The effect of exercise on postprandial lipidemia in type 2 diabetic patients Eur. J. Appl. Physiol. 102 2008 361 370
182. A.J. Tremblay, B. Lamarche, J.S. Cohn, J.C. Hogue, and P. Couture Effect of ezetimibe on the in vivo kinetics of apoB-48 and apoB-100 in men with primary hypercholesterolemia Arterioscler. Thromb. Vasc. Biol. 26 2006 1101 1106
183. A.J. Tremblay, B. Lamarche, J.C. Hogue, and P. Couture Effects of ezetimibe and simvastatin on apolipoprotein B metabolism in males with mixed hyperlipidemia J. Lipid Res. 50 2009 1463 1471
184. A.J. Tremblay, B. Lamarche, I. Ruel, J.C. Hogue, J. Bergeron, C. Gagne, and P. Couture Lack of evidence for reduced plasma apo B48 catabolism in patients with heterozygous familial hypercholesterolemia carrying the same null LDL receptor gene mutation Atherosclerosis 172 2004 367 373
185. A.J. Tremblay, B. Lamarche, I.L. Ruel, J.C. Hogue, Y. Deshaies, C. Gagne, and P. Couture Effects of fenofibrate on apolipoprotein kinetics in patients with coexisting dysbetalipoproteinemia and heterozygous familial hypercholesterolemia Atherosclerosis 188 2006 203 212
186. T. Twickler, G.M. Dallinga-Thie, M.J. Chapman, and J.S. Cohn Remnant lipoproteins and atherosclerosis Curr. Atheroscler. Rep. 7 2005 140 147
187. J.P. van Wijk, E.J. de Koning, C.M. Castro, and T.J. Rabelink Rosiglitazone improves postprandial triglyceride and free fatty acid metabolism in type 2 diabetes Diabetes Care 28 2005 844 849
188. W. Velez-Carrasco, A.H. Lichtenstein, P.H. Barrett, Z. Sun, G.G. Dolnikowski, F.K. Welty, and E.J. Schaefer Human apolipoprotein A-I kinetics within triglyceride-rich lipoproteins and high density lipoproteins J. Lipid Res. 40 1999 1695 1700
189. C.J. Villanueva, M. Monetti, M. Shih, P. Zhou, S.M. Watkins, S. Bhanot, and R.V. Farese Jr. Specific role for acyl CoA:Diacylglycerol acyltransferase 1 (Dgat1) in hepatic steatosis due to exogenous fatty acids Hepatology 50 2009 434 442
190. D.F. Vine, R. Takechi, J.C. Russell, and S.D. Proctor Impaired postprandial apolipoprotein-B48 metabolism in the obese, insulin-resistant JCR:LA-cp rat: increased atherogenicity for the metabolic syndrome Atherosclerosis 190 2007 282 290
191. Y. Wang, M.M. Jacome-Sosa, M.R. Ruth, S.D. Goruk, M.J. Reaney, D.R. Glimm, D.C. Wright, D.F. Vine, C.J. Field, and S.D. Proctor Trans-11 vaccenic acid reduces hepatic lipogenesis and chylomicron secretion in JCR:LA-cp rats J. Nutr. 139 2009 2049 2054
192. T. Wasada, K. McCorkle, V. Harris, K. Kawai, B. Howard, and R.H. Unger Effect of gastric inhibitory polypeptide on plasma levels of chylomicron triglycerides in dogs J. Clin. Invest. 68 1981 1106 1107
193. G.F. Watts, P.H. Barrett, A.D. Marais, C.A. Dane-Stewart, I.J. Martins, S.B. Dimmitt, and T.G. Redgrave Chylomicron remnant metabolism in familial hypercholesterolaemia studied with a stable isotope breath test Atherosclerosis 157 2001 519 523
194. F.K. Welty, A.H. Lichtenstein, P.H. Barrett, G.G. Dolnikowski, and E.J. Schaefer Human apolipoprotein (Apo) B-48 and ApoB-100 kinetics with stable isotopes Arterioscler. Thromb. Vasc. Biol. 19 1999 2966 2974
195. F.K. Welty, A.H. Lichtenstein, P.H. Barrett, G.G. Dolnikowski, and E.J. Schaefer Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes Arterioscler. Thromb. Vasc. Biol. 24 2004 1703 1707
196. F.K. Welty, A.H. Lichtenstein, P.H. Barrett, J.L. Jenner, G.G. Dolnikowski, and E.J. Schaefer Effects of ApoE genotype on ApoB-48 and ApoB-100 kinetics with stable isotopes in humans Arterioscler. Thromb. Vasc. Biol. 20 2000 1807 1810
197. J.R. Wetterau, L.P. Aggerbeck, M.E. Bouma, C. Eisenberg, A. Munck, M. Hermier, J. Schmitz, G. Gay, D.J. Rader, and R.E. Gregg Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia Science 258 1992 999 1001
198. D.A. White, A.J. Bennett, M.A. Billett, and A.M. Salter The assembly of triacylglycerol-rich lipoproteins: an essential role for the microsomal triacylglycerol transfer protein Br. J. Nutr. 80 1998 219 229
199. C.J. Willer, S. Sanna, A.U. Jackson, A. Scuteri, L.L. Bonnycastle, R. Clarke, S.C. Heath, N.J. Timpson, S.S. Najjar, H.M. Stringham, J. Strait, W.L. Duren, A. Maschio, F. Busonero, A. Mulas, G. Albai, A.J. Swift, M.A. Morken, N. Narisu, D. Bennett, S. Parish, H. Shen, P. Galan, P. Meneton, S. Hercberg, D. Zelenika, W.M. Chen, Y. Li, L.J. Scott, P.A. Scheet, J. Sundvall, R.M. Watanabe, R. Nagaraja, S. Ebrahim, D.A. Lawlor, Y. Ben-Shlomo, G. Davey-Smith, A.R. Shuldiner, R. Collins, R.N. Bergman, M. Uda, J. Tuomilehto, A. Cao, F.S. Collins, E. Lakatta, G.M. Lathrop, M. Boehnke, D. Schlessinger, K.L. Mohlke, and G.R. Abecasis Newly identified loci that influence lipid concentrations and risk of coronary artery disease Nat. Genet. 40 2008 161 169
200. C. Xiao, J. Hsieh, K. Adeli, and G.F. Lewis Gut-liver interaction in triglyceride-rich lipoprotein metabolism Am. J. Physiol. Endocrinol. Metab. 301 2011 E429 E446
201. C. Xiao, M. Pavlic, L. Szeto, B.W. Patterson, and G.F. Lewis Effects of acute hyperglucagonemia on hepatic and intestinal lipoprotein production and clearance in healthy humans Diabetes 60 2011 383 390
202. Y. Yao, S. Lu, Y. Huang, C.C. Beeman-Black, R. Lu, X. Pan, M.M. Hussain, and D.D. Black Regulation of microsomal triglyceride transfer protein by apolipoprotein A-IV in newborn swine intestinal epithelial cells Am. J. Physiol. Gastrointest. Liver Physiol. 300 2011 G357 G363
203. C.L. Yen, M.L. Cheong, C. Grueter, P. Zhou, J. Moriwaki, J.S. Wong, B. Hubbard, S. Marmor, and R.V. Farese Jr. Deficiency of the intestinal enzyme acyl CoA:monoacylglycerol acyltransferase-2 protects mice from metabolic disorders induced by high-fat feeding Nat. Med. 15 2009 442 446
204. C.L. Yen, S.J. Stone, S. Cases, P. Zhou, and R.V. Farese Jr. Identification of a gene encoding MGAT1, a monoacylglycerol acyltransferase Proc. Natl. Acad. Sci. U. S. A. 99 2002 8512 8517
205. C. Zheng, K. Ikewaki, B.W. Walsh, and F.M. Sacks Metabolism of apoB lipoproteins of intestinal and hepatic origin during constant feeding of small amounts of fat J. Lipid Res. 47 2006 1771 1779
206. M. Zoltowska, E. Ziv, E. Delvin, D. Sinnett, R. Kalman, C. Garofalo, E. Seidman, and E. Levy Cellular aspects of intestinal lipoprotein assembly in Psammomys obesus: a model of insulin resistance and type 2 diabetes Diabetes 52 2003 2539 2545